Cargando...
Targeting alpha-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies
OBJECTIVE: Reducing the burden of alpha-synuclein oligomeric species represents a promising approach for disease-modifying therapies against synucleinopathies such as Parkinson's disease and dementia with Lewy bodies. However, the lack of efficient drug discovery strategies that specifically ta...
Gardado en:
| Publicado en: | Expert Opin Ther Targets |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4608017/ https://ncbi.nlm.nih.gov/pubmed/25785645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14728222.2015.1009448 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|